Cargando…
Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population
BACKGROUND: Genetic polymorphisms of cytochrome P450 enzymes, especially CYP2C19 influence voriconazole pharmacokinetics. However, the impact of CYP2C19 genetic polymorphisms on the therapeutic efficacy and toxicity of voriconazole therapy are not well established. MATERIALS AND METHODS: In this pro...
Autores principales: | Kim, Si-Hyun, Lee, Dong-Gun, Kwon, Jae-Cheol, Lee, Hyo-Jin, Cho, Sung-Yeon, Park, Chulmin, Kwon, Eun-Young, Park, Sun Hee, Choi, Su-Mi, Choi, Jung-Hyun, Yoo, Jin-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902809/ https://www.ncbi.nlm.nih.gov/pubmed/24475354 http://dx.doi.org/10.3947/ic.2013.45.4.406 |
Ejemplares similares
-
Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study
por: Kim, Sun Bean, et al.
Publicado: (2017) -
Real-Time Nucleic Acid Sequence-Based Amplification to Predict the Clinical Outcome of Invasive Aspergillosis
por: Kim, Si-Hyun, et al.
Publicado: (2012) -
Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency
por: Lee, Yena, et al.
Publicado: (2020) -
Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017) -
Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects
por: Han, Ji Min, et al.
Publicado: (2020)